SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Exagen Inc. – ‘10-K’ for 12/31/19 – ‘R62’

On:  Wednesday, 3/25/20, at 5:17pm ET   ·   For:  12/31/19   ·   Accession #:  1274737-20-26   ·   File #:  1-39049

Previous ‘10-K’:  None   ·   Next:  ‘10-K’ on 3/16/21 for 12/31/20   ·   Latest:  ‘10-K’ on 3/18/24 for 12/31/23   ·   8 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 3/25/20  Exagen Inc.                       10-K       12/31/19   88:11M

Annual Report   —   Form 10-K   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML   1.33M 
 2: EX-10.27    Material Contract                                   HTML     29K 
 3: EX-10.28    Material Contract                                   HTML     33K 
 4: EX-10.29    Material Contract                                   HTML     53K 
 5: EX-10.31    Material Contract                                   HTML     32K 
 6: EX-10.32    Material Contract                                   HTML     87K 
 7: EX-10.33    Material Contract                                   HTML    269K 
 8: EX-10.36    Material Contract                                   HTML     59K 
 9: EX-10.41    Material Contract                                   HTML     28K 
10: EX-23.1     Consent of Experts or Counsel                       HTML     25K 
11: EX-31.1     Certification -- §302 - SOA'02                      HTML     31K 
12: EX-31.2     Certification -- §302 - SOA'02                      HTML     31K 
13: EX-32.1     Certification -- §906 - SOA'02                      HTML     28K 
28: R1          Cover                                               HTML     91K 
62: R2          Condensed Balance Sheets                            HTML     98K 
85: R3          Unaudited Condensed Statements of Operations        HTML     79K 
40: R4          Unaudited Condensed Statements of Redeemable        HTML    111K 
                Convertible Preferred Stock and Stockholders'                    
                Equity                                                           
27: R5          Statements of Cash Flows                            HTML    142K 
61: R6          Unaudited Condensed Statements of Redeemable        HTML     32K 
                Convertible Preferred Stock and Stockholders'                    
                Equity (Deficit) (Parenthetical)                                 
84: R7          Condensed Balance Sheets - (Parenthetical)          HTML     66K 
38: R8          Statement of Cash Flows (Parenthetical)             HTML     26K 
29: R9          Organization - (Notes)                              HTML     35K 
71: R10         Summary Of Significant Accounting Policies -        HTML    147K 
                (Notes)                                                          
80: R11         Other Financial Information - (Notes)               HTML     81K 
52: R12         Borrowings - (Notes)                                HTML     49K 
22: R13         Warrants to Purchase Common or Preferred Stock -    HTML     45K 
                (Notes)                                                          
72: R14         Commitment and Contingencies - (Notes)              HTML     52K 
81: R15         Fair Value Measurements - (Notes)                   HTML     65K 
53: R16         Redeemable Convertible Preferred Stock              HTML     39K 
23: R17         Stockholders' Equity (Deficit)                      HTML     30K 
73: R18         Stock Option Plan                                   HTML     87K 
79: R19         Income Taxes                                        HTML    102K 
42: R20         Related Parties                                     HTML     31K 
30: R21         401(k) Plan                                         HTML     27K 
58: R22         Subsequent Events                                   HTML     30K 
82: R23         Summary Of Significant Accounting Policies -        HTML    107K 
                Policies                                                         
43: R24         Summary Of Significant Accounting Policies -        HTML    119K 
                (Tables)                                                         
31: R25         Other Financial Information - (Tables)              HTML     84K 
59: R26         Borrowings - (Tables)                               HTML     38K 
83: R27         Warrants to Purchase Common or Preferred Stock -    HTML     44K 
                (Tables)                                                         
41: R28         Commitment and Contingencies (Tables)               HTML     65K 
32: R29         Fair Value Measures and Disclosures (Tables)        HTML     67K 
26: R30         Stock Option Plan (Tables)                          HTML     90K 
56: R31         Income Taxes (Tables)                               HTML    103K 
78: R32         Organization - (Details)                            HTML     51K 
70: R33         Summary Of Significant Accounting Policies -        HTML     52K 
                Narrative (Details)                                              
25: R34         Summary Of Significant Accounting Policies -        HTML     52K 
                Revenue by Major Payers (Details)                                
54: R35         Summary Of Significant Accounting Policies -        HTML     38K 
                Disaggregation of Revenue (Details)                              
77: R36         Summary Of Significant Accounting Policies - Cash,  HTML     35K 
                cash equivalents and restricted cash (Details)                   
69: R37         Summary Of Significant Accounting Policies -        HTML     36K 
                Securities (Details)                                             
24: R38         Other Financial Information - Narrative (Details)   HTML     32K 
57: R39         Other Financial Information - Prepaid expenses      HTML     38K 
                (Details)                                                        
36: R40         Other Financial Information - Property and          HTML     45K 
                equipment (Details)                                              
45: R41         Other Financial Information - Accrued liabilities   HTML     48K 
                (Details)                                                        
88: R42         Borrowings - Narrative (Details)                    HTML     78K 
66: R43         Borrowings - Future minimum payments (Details)      HTML     49K 
34: R44         Warrants to Purchase Common or Preferred Stock -    HTML     36K 
                Narrative (Details)                                              
44: R45         Warrants to Purchase Common or Preferred Stock -    HTML     40K 
                Outstanding warrants (Details)                                   
87: R46         Commitment and Contingencies - Narrative (Details)  HTML     55K 
65: R47         Commitment and Contingencies - Minimum annual       HTML     69K 
                lease payments under non-cancelable lease                        
                arrangements (Details)                                           
33: R48         Fair Value Measurements - Fair value measurement    HTML     45K 
                (Details)                                                        
46: R49         Fair Value Measurements- Fair value level 3         HTML     42K 
                (Details)                                                        
49: R50         Redeemable Convertible Preferred Stock (Details)    HTML     83K 
19: R51         Stockholders' Equity (Deficit) (Details)            HTML     49K 
67: R52         Stock Option Plan - Narrative (Details)             HTML     71K 
74: R53         Stock Option Plan - Stock Option Activity           HTML     83K 
                (Details)                                                        
51: R54         Stock Option Plan - Fair Value Assumptions          HTML     46K 
                (Details)                                                        
20: R55         Stock Option Plan - Stock-Based Compensation        HTML     34K 
                Expense (Details)                                                
68: R56         Stock Option Plan - Common Stock Reserved For       HTML     35K 
                Future Issuance (Details)                                        
75: R57         Income Taxes (Details)                              HTML     39K 
48: R58         Income Taxes - Components of Income Tax Expense     HTML     48K 
                (Benefit) (Details)                                              
21: R59         Income Taxes - Reconciliation of Effective Income   HTML     47K 
                Tax Rate (Details)                                               
63: R60         Income Taxes - Reconciliation of Deferred Tax       HTML     61K 
                Assets and Liabilities (Details)                                 
86: R61         Income Taxes - Change In Valuation Allowance        HTML     31K 
                (Details)                                                        
47: R62         Related Parties (Details)                           HTML     45K 
37: R63         401(k) Plan (Details)                               HTML     28K 
64: R64         Subsequent Events (Details)                         HTML     42K 
39: R9999       Uncategorized Items - exdx-20191231.htm             HTML     25K 
55: XML         IDEA XML File -- Filing Summary                      XML    147K 
35: XML         XBRL Instance -- exdx-20191231_htm                   XML   1.84M 
50: EXCEL       IDEA Workbook of Financial Reports                  XLSX     87K 
15: EX-101.CAL  XBRL Calculations -- exdx-20191231_cal               XML    235K 
16: EX-101.DEF  XBRL Definitions -- exdx-20191231_def                XML    679K 
17: EX-101.LAB  XBRL Labels -- exdx-20191231_lab                     XML   1.77M 
18: EX-101.PRE  XBRL Presentations -- exdx-20191231_pre              XML   1.03M 
14: EX-101.SCH  XBRL Schema -- exdx-20191231                         XSD    172K 
76: JSON        XBRL Instance as JSON Data -- MetaLinks              364±   562K 
60: ZIP         XBRL Zipped Folder -- 0001274737-20-000026-xbrl      Zip    733K 


‘R62’   —   Related Parties (Details)


This is an IDEA Financial Report.  [ Alternative Formats ]



 
v3.20.1
Related Parties (Details) - USD ($)
$ / shares in Units, $ in Thousands
1 Months Ended 12 Months Ended
Related Party Transaction [Line Items]        
Issued during period (in Shares)     816,356  
Common stock options, exercise price (in dollars per share)     $ 13.99  
Board Member | Consulting services        
Related Party Transaction [Line Items]        
Expenses incurred with related party (bi-weekly rate) $ 5   $ 130 $ 126
Issued during period (in Shares)   544    
Common stock options, exercise price (in dollars per share)   $ 0.367    
Stock options, vesting period     3 years  
Chief Scientific Officer | License Agreement        
Related Party Transaction [Line Items]        
Royalty obligation, percent of net sales     5.00%  
Milestone obligation     $ 600  

Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-K’ Filing    Date    Other Filings
Filed on:3/25/208-K
For Period end:12/31/19
12/31/18
6/30/18
11/30/17
 List all Filings 


8 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/18/24  Exagen Inc.                       10-K       12/31/23   76:8.9M
 5/04/23  Exagen Inc.                       8-K:1,2,9   4/28/23   11:241K
 3/20/23  Exagen Inc.                       10-K       12/31/22   76:9.1M
 3/22/22  Exagen Inc.                       10-K       12/31/21   73:8.6M                                   Workiva Inc Wde… FA01/FA
 4/01/21  Exagen Inc.                       10-K/A     12/31/20   14:498K
 3/23/21  Exagen Inc.                       424B5                  1:601K                                   Donnelley … Solutions/FA
 3/22/21  Exagen Inc.                       424B5                  1:599K                                   Donnelley … Solutions/FA
 3/16/21  Exagen Inc.                       10-K       12/31/20   78:8.7M
Top
Filing Submission 0001274737-20-000026   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Mon., May 13, 4:34:32.2pm ET